Article info

Download PDFPDF

Monalizumab: inhibiting the novel immune checkpoint NKG2A

Authors

  1. a T.van_Hall{at}lumc.nl
  2. i Vivier{at}ciml.univ-mrs.fr
View Full Text

Citation

van Hall T, André P, Horowitz A, et al
Monalizumab: inhibiting the novel immune checkpoint NKG2A

Publication history

  • Received May 31, 2019
  • Accepted September 26, 2019
  • First published October 17, 2019.
Online issue publication 
October 17, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.